CClinicalTrials.gg
CompletedNCT04591080Updated May 30, 2025Results posted

A Comparison Between GUMMETAL and SS Orthodontic Wires in Space Closure

An interventional study of GUMMETAL Orthodontic Wire and Stainless Steel (CrNi) in Malocclusion, Angle Class I, sponsored by State University of New York at Buffalo. Completed at 1 site in United States. Open to participants aged 12 Years to 17 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-05-30.

Sponsored by State University of New York at Buffalo · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
12
Allocation
Randomized
Ages
12 Years to 17 Years
Sex
All
01

Study summary

When there is space present between our teeth orthodontically we have the ability to close them through many methods. Using braces as our treatment modality this study will be investigating how efficient a new orthodontic wire is in closing tooth space. This new material is trade-named GUMMETAL and claims to have many benefits to treating patients orthodontically. We will be exploring its efficiency in space closure compared to an industry standard (stainless steel). We predict that the stainless-steel orthodontic wire will be more efficient at space closure than the new GUMMETAL wires.

Read the detailed description

This will be a randomized pilot split-mouth clinical trial of patients with spaces ≥ 3mm distal to the maxillary canines in need of closure through sliding mechanics. The sample consists of adolescent patients regardless of Angle's molar malocclusion who are receiving comprehensive full fixed appliance orthodontic treatment. Preformed conjoint archwires half being GUMMETAL and the other half SS, will be utilized. Each patient will have one side of the maxilla randomly allocated into the SS or GUMMETAL treatment group. The study will follow a split-mouth design to reduce the confounding variables from patient to patient on space closure mechanics. The maxillary arch in each subject will be randomized into a SS side or GM side using a random number generator. Spaces will be measured at; T0 is initial records, T1 is initiation of space closure, T2 will be 4 weeks after the initiation of space closure, T3 is another 4 weeks of space closure evaluation and T4 will be the final evaluation of space closure after 4 weeks from T3, via 3D intraoral scans of maxillary arches. Space measurement and calculations will utilize 3Shape software to measure the distance of canine movement based off the distal surface. Sliding mechanics will be activated through NiTi coil springs from the maxillary canines to the maxillary molars. The force will be standardized to 150 gms and will be measured each visit. The same provider will activate the NiTi coil spring for retraction, along with data collection. Superimposition of scans will be utilized to assess outcome measures.

02

Conditions studied

  • Malocclusion, Angle Class I
03

Who can participate

Ages eligible
12 Years to 17 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Full permanent dentition (except third molars)
  • Good general and oral health
  • Bilateral spaces 3 >/= mm distal to the maxillary canines
  • Normal and hypodivergent growth pattern
  • Any dental malocclusion
  • Good Oral Hygiene

Exclusion criteria

Exclusion Criteria:

  • Systemic diseases or syndrome
  • Abnormalities in teeth size and/or shape
  • Previous orthodontic treatment
  • Anti-inflammatory medication
  • Craniofacial anomalies
  • Hyperdivergent growth pattern
  • Periodontal disease / attachment loss exceeding 25% of root length
  • Significant pre or in-treatment root resorption
04

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Single group
Masking
Single (Participant)
Enrollment
12 participants (actual)

Study arms

  • Experimental
    GUMMETAL TiNbTaZr

    TiNbTaZr (Beta-Titanium) Alloy used to manufacture orthodontic archwires. We will be using an archwire with the size of 0.016 x 0.022"

    Device: GUMMETAL Orthodontic Wire

  • Active comparator
    Stainless Steel (CrNi)

    Stainless steel (18% Chromium and 8% Nickel) used as the control, and linked anteriorly to the GUMMETAL counterpart. Size of archwire is 0.016 x 0.022"

    Device: Stainless Steel (CrNi)

Interventions

  • DeviceGUMMETAL Orthodontic Wire

    Orthodontic archwire made of TiNbTaZr alloy.

    Also known as: TiNbTaZr, Titanium-niobium, Beta-titanium,

  • DeviceStainless Steel (CrNi)

    Stainless steel (18% Chromium and 8% Nickel) used as the control, and linked anteriorly to the GUMMETAL counterpart. Size of archwire is 0.016 x 0.022"

05

What researchers measure

Primary outcomes

  1. Total Amount of Canine Retraction

    Canine movement measured at distal marginal ridge

    Time frame: 12 weeks

Secondary outcomes

  1. 3-Dimensional Control of Canine Movement Assessment

    Canine position (tip, rotation, angulation) will be assessed from initial to final position

    Time frame: 12 weeks

  2. Rate of Canine Retraction Per Month

    Rate of canine retraction in mm per month

    Time frame: 12 weeks

06

Results

Posted Apr 19, 2024

Participant flow

Participant flow — Overall Study
MilestoneControlIntervention
Started1212
Completed66
Not completed66

Outcome measures

PrimaryTotal Amount of Canine Retraction

Canine movement measured at distal marginal ridge

Time frame:
12 weeks
Reported as:
Median · mm
Total Amount of Canine Retraction
mmGUMMETAL TiNbTaZrStainless Steel (CrNi)
Total Amount of Canine Retraction3.41 (2.10 to 4.76)3.71 (1.62 to 6.45)
Secondary3-Dimensional Control of Canine Movement Assessment

Canine position (tip, rotation, angulation) will be assessed from initial to final position

Time frame:
12 weeks
Reported as:
Median · degrees
3-Dimensional Control of Canine Movement Assessment
degreesGUMMETAL TiNbTaZrStainless Steel (CrNi)
3-Dimensional Control of Canine Movement Assessment7.90 (6.74 to 8.99)7.25 (6.71 to 8.16)
SecondaryRate of Canine Retraction Per Month

Rate of canine retraction in mm per month

Time frame:
12 weeks
Reported as:
Median · mm/month
Rate of Canine Retraction Per Month
mm/monthGUMMETAL TiNbTaZrStainless Steel (CrNi)
Rate of Canine Retraction Per Month1.14 (0.69 to 1.59)1.42 (0.54 to 2.15)

Adverse events

Collected over Throughout study completion: An average of 6 months. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
All Participants0/12 (0%)0/12 (0%)0/12 (0%)

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)All Participants
<=18 years12
Between 18 and 65 years0
>=65 years0
Sex: Female, Male
Sex: Female, Male(Participants)All Participants
Female9
Male3
Race and Ethnicity Not Collected
Race and Ethnicity Not Collected(Participants)All Participants
07

Study locations

1 site
  • University at Buffalo
    Buffalo, New York 14214, United States
08

References and documents

Study documents

  • Protocol and statistical analysis plan · Sep 25, 2021
  • Informed consent form · Aug 12, 2020

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No — We will not be sharing any IPD information with any other researchers.

09

Registry details

Key details

Study ID
NCT04591080
Lead sponsor
State University of New York at Buffalo
Responsible party
Lubomyr Ravlyk (Orthodontic Resident, State University of New York at Buffalo) — Principal investigator
First posted
Oct 19, 2020
Start date
Sep 1, 2020
Primary completion
Mar 1, 2022
Completion
Mar 1, 2022
Results posted
Apr 19, 2024
Last update
May 30, 2025

Study contacts

Thikriat Al-Jewair
study chair · University at Buffalo

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion